Article

Description of Resource:

The Advisory Committee on Immunization Practices provides recommendations for the use of quadrivalent human papillomavirus vaccine in both males and females.

Evidence-Based Resource Details

Learn more about EBR criteria

Developed By:

CDC/MMWR

Developer Type:

Federal Government

Healthy People 2020 Topic Area(s):

Sexually Transmitted Diseases

Resource Type:

Systematic Review

Citation:

Centers for Disease Control and Prevention. FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR [Internet]. 2010 May 28 [cited 2015 Jul 24];59:626–629. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm

Tags:

Reduce Risk or Incidence of Disease or Condition, Public Health, Government & Policymakers, Healthcare, Clinical Practice, Primary Prevention, Patients

Syndicated Content Details:
Source URL: https://www.healthypeople.gov/2020/tools-resources/evidence-based-resource/fda-licensure-of-bivalent-human-papillomavirus-vaccine
Source Agency: Office of Disease Prevention and Health Promotion, Healthy People (ODPHP-HP)
Captured Date: 2016-06-09 15:55:08.0